Právní předpis byl sestaven k datu 08.12.2025.
Zobrazené znění právního předpisu je účinné od 17.12.2016.
Sdělení o antigenním složení očkovacích látek pro pravidelná, zvláštní a mimořádná očkování pro rok 2017
390/2016 Sb.
390
XXXXXXX
Xxxxxxxxxxxx zdravotnictví
ze dne 28. xxxxxxxxx 2016
x xxxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx pro xxxxxxxxxx, xxxxxxxx x xxxxxxxxx xxxxxxxx xxx rok 2017
Xxxxxxxxxxxx xxxxxxxxxxxxx podle §80 xxxx. 1 xxxx. x) zákona x. 258/2000 Sb., x xxxxxxx veřejného xxxxxx x o xxxxx některých souvisejících xxxxxx, xx znění xxxxxxxxxx xxxxxxxx, xxxxxxx xx xxxxxxx xxxxxxxxxx Xxxxxxx xxxxxxxxxx komise xxxxxxxxx složení xxxxxxxxxx xxxxx xxx pravidelná, xxxxxxxx x xxxxxxxxx xxxxxxxx xxx rok 2017:
1. Xxxxxxxxx xxxxxxx xxxxxxxxxx látek xxx xxxxxxxxxx očkování
1a) xxxxxxxxxxx xxxxxxxx látka proti xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), tetanu, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx), virové xxxxxxxxxx B, nákazám xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx xxx x (DTaPHibVHBIPV):
Diphtheriae xxxxxxxxxx1 ne méně xxx 30 xxxxxxxxxxxxx xxxxxxxx (IU)
Tetani xxxxxxxxxx1 xx méně než 40 xxxxxxxxxxxxx xxxxxxxx (XX)
Xxxxxxxx Xxxxxxxxxx pertussis:
Pertussis xxxxxxxxxx1 25 mikrogramů
Haemagglutininum xxxxxxxxxxxx1 25 mikrogramů
Pertactinum1 8 xxxxxxxxxx
Xxxxxxxxx tegiminis xxxxxxxxxxx X2,3 10 xxxxxxxxxx
Xxxxx xxxxxxxxxxxxx (inaktivovaný)
typus 1 (xxxx Xxxxxxx)4 40 X xxxxxxxx xxxxxxxx
xxxxx 2 (kmen XXX-1)4 8 X xxxxxxxx xxxxxxxx
xxxxx 3 (xxxx Xxxxxxx)4 32 X jednotek xxxxxxxx
Xxxxxxxxxxx xxxxxxxxxx xxxxx x xxxxxxxxxxxxxxx 10 mikrogramů
(polyribosylribitoli xxxxxxxx)3
xxxxxxxxx xxx xxxxxx xxxxxxxxxx jako nosným xxxxxxxxx xxxxxxxxx 25 xxxxxxxxxx
XXXX
1xx) xxxxxxxxxxx očkovací xxxxx proti xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx xxxxxxxx obrně (xxxxxxxxxxxx xxxxx), xxxxxx xxxxxxxxxx X, xxxxxxx vyvolaným Xxxxxxxxxxx xxxxxxxxxx typ x (XXxXXxxXXXXXX)
Xxxxxxxxxxx anatoxinum xx méně xxx 20 mezinárodních xxxxxxxx (XX)2
Xxxxxx xxxxxxxxxx ne xxxx xxx 40 xxxxxxxxxxxxx xxxxxxxx (XX)2
Xxxxxxxx Xxxxxxxxxx xxxxxxxxx
Xxxxxxxxx xxxxxxxxxx 25 xxxxxxxxxx
Xxxxxxxxxxxxxx xxxxxxxxxxxx 25 mikrogramů
Virus Xxxxxxxxxxxxxxx (xxxxxxxxxxxx)3
xxxxx 1 (Xxxxxxx) 40 X xxxxxxxx xxxxxxxx4
xxxxx 2 (XXX-1) 8 X xxxxxxxx xxxxxxxx4
xxxxx 3 (Xxxxxxx) 32 X xxxxxxxx xxxxxxxx4
Xxxxxxxxx tegiminis hepatitidy X5 10 xxxxxxxxxx
Xxxxxxxxxxx xxxxxxxxxx xxxx x xxxxxxxxxxxxxxx 12 xxxxxxxxxx
(Xxxxxxxxxxxxxxxxxxx xxxxxxxx)
xxxxxxxxx xxx xxxxxx xxxxxxxxxx 22-36 xxxxxxxxxx
1x) xxxxxxxx xxxxx proti xxxxxxx, xxxxxxxx kašli (xxxxxxxxxx forma), tetanu (XXxX):
Xxxxxxxxxxx xxxxxxxxxx ³ 30 xxxxxxxxxxxxx xxxxxxxx
Xxxxxx xxxxxxxxxx ³ 40 xxxxxxxxxxxxx xxxxxxxx
Xxxxxxxxx xxxxxxxxxx (XX) 25 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxxx filamentosum (XXX) 25 mikrogramů
Pertactinum (69xX) 8 xxxxxxxxxx
XXXX
1xx) Očkovací xxxxx xxxxx xxxxxxx, xxxxxx a xxxxxxxx xxxxx (xxxxxxxxxx)
|
1 xxxxx (0,5 xx) obsahuje: Xxxxxxxxxxx xxxxxxxxxx |
Xxxxxxxxx 2 XX* (2 Xx) |
|
Xxxxxx xxxxxxxxxx |
Xxxxxxxxx 20 IU* (5 Xx) |
|
Xxxxxxxxx antigeny |
|
|
Pertussis xxxxxxxxxx |
2,5 xxxxxxxxxx |
|
Xxxxxxxxxxxxxx xxxxxxxxxxxx |
5 xxxxxxxxxx |
|
Xxxxxxxxxxx |
3 xxxxxxxxxx |
|
Xxxxxxxx, xxxx 2 xx 3 |
5 xxxxxxxxxx |
|
Xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxx |
1,5 xx (0,33 xx xxxxxxx) |
XXXX
1xx) Xxxxxxxx xxxxx proti xxxxxxx, xxxxxx x dávivému xxxxx (xxxxxxxxxx xxxxxxxxxx) xx xxxxxxxx obsahem xxxxxxxx
Xxxxxxxxxxx xxxxxxxxxx1 xx xxxx než 2 xxxxxxxxxxx xxxxxxxx (XX) (2,5 Lf)
Tetani anatoxinum1 xx xxxx xxx 20 mezinárodních xxxxxxxx (XX) (5 Xx)
Xxxxxxxxxxx xxxxxxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxxx1 8 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxxx1 8 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxx externae xxxxxxxxx1 2,5 xxxxxxxxxx
1 xxxxxxxxxxx xx hydratovaný xxxxxxxx xxxxxxx (AI(OH)3) 0,3 xxxxxxxxx XX3+
x xxxxxxxxxxx xxxxxxx (XXX04) 0,2 xxxxxxxxx AI3+
1c) xxxxxxxx xxxxx proti xxxxxxx, xxxxxxxx kašli (xxxxxxxxxx xxxxx), xxxxxx, xxxxxxx xxxxxxxxx Xxxxxxxxx xxxxxxxxxx x (XXxXXxx):
|
Xxxxxxxxxxx xxxxxxxxxx |
xxx. 30 xxxxxxxxxxxxx xxxxxxxx |
|
Xxxxxx xxxxxxxxxx |
xxx. 40 mezinárodních xxxxxxxx |
|
Xxxxxxxxx xxxxxxxxxx (PT) |
25 xxxxxxxxxx |
|
Xxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxxx |
(XXX) 25 mikrogramů |
|
Pertactinum (69kD) |
8 xxxxxxxxxx |
|
Xxxxxxxxxxx influenzae B |
10 xxxxxxxxxx |
|
xxx xxxxxxxxx xxxxxxxx |
20-40 xxxxxxxxxx |
1x) očkovací látka xxxxx xxxxxxx xxxxxxxxx Xxxxxxxxxxx influenzae xxx x:
1 xxxxx lyofilizované xxxxxxx xxxxxxxx: Polysaccharidum Xxx xxxxxxxxxxx (10 xxxxxxxxxx) xxx Xxxxxxxxx xxxxxxxx (xxxxxxxxx 25 xxxxxxxxxx).
1x) xxxxxxxx xxxxx xxxxx tetanu:
Tetani anatoxinum … min. 40 xxxxxxxxxxxxx jednotek
1f) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx B xx 16 xxx a xxxx:
|
Xxxxxxxxx tegiminis xxxxxxxxxxx X |
20 xxxxxxxxxx |
1x) očkovací xxxxx xxxxx xxxxxx xxxxxxxxxx X x xxxxxx xxxxxxx:
|
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X |
10 xxxxxxxxxx |
1x) xxxxxxxx látka proti xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxx:
Xxxxxxxxxxx xxxxx xxxxxxxxxx (Xxxxxxx) xxx. 103,0 xxxxxxxx dávka xxx xxxxxxxx xxxxxxx50 Xxxxxxxxxxx xxxxx attenuatum (XXX 4385) min. 103,7 xxxxxxxx dávka xxx xxxxxxxx xxxxxxx50 Rubeolae xxxxx attenuatum (Xxxxxx XX 27/3) xxx. 103,0 xxxxxxxx dávka xxx xxxxxxxx xxxxxxx50
1xx) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxx obrně x xxxxxxxxxxxx formě:
Virus xxxxxxxxxxxxx xxxxxxxxxxx xxxxx 1 (Xxxxxxx) … 40 xxxxxxxxxxx D xxxxxxxx*
Xxxxx xxxxxxxxxxxxx inactivatum xxxxx 2 (MEF-1) … 8 xxxxxxxxxxx X jednotek*
Virus xxxxxxxxxxxxx xxxxxxxxxxx typus 3 (Xxxxxxx) … 32 xxxxxxxxxxx X xxxxxxxx*
* xxxx xxxxxxxx ekvivalentních xxxxxxxx stanovené xxxxxx xxxxxx imunochemické xxxxxx.
1x) xxxxxxxx látka xxxxx xxxxxxx xxxxxxxxx Xxxxxxxxxxxxx xxxxxxxxxx x polysacharidové xxxxxxx:
Xxxxxxxxxxxxxxx Streptococci xxxxxxxxxx xxxxx:
1, 2, 3, 4, 5, 6X, 7X, 8, 9N, 9X, 10A, 11X, 12X, 14, 15X, 17X,
18X, 19X, 19F, 20, 22F, 23X, 33X … 25 xxxxxxxxxx z xxxxxxx xxxxxxxx
1x) očkovací xxxxx xxxxxxxxxxx xxxxx xxxxxxxxxxxxx xxxxxxxx:
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 1
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 3
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 4
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 5
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 6X
Xxxxxxxxxxxxx polysaccharidum xxxxxxxxx 6X
Xxxxxxxxxxxxx polysaccharidum xxxxxxxxx 7X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 9X
Xxxxxxxxxxxxx polysaccharidum sérotypus 14
Xxxxxxxxxxxxx polysaccharidum xxxxxxxxx 18X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 19X
Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 19X
Xxxxxxxxxxxxx polysaccharidum sérotypus 23X
1x) očkovací látka xxxxx záškrtu, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx přenosné xxxxx (xxxxxxxxxxxx xxxxx):
|
Xxxxxxxxxxx anatoxinum |
ne xxxx xxx 2 xxxxxxxxxxx xxxxxxxx |
|
Xxxxxx anatoxinum |
ne xxxx xxx 20 xxxxxxxxxxxxx xxxxxxxx |
|
Xxxxxxxxx xxxxxxxx: |
|
|
Xxxxxxxxx xxxxxxxxxx |
8 xxxxxxxxxx |
|
Xxxxxxxxx haemagglutinum filamentosum |
8 xxxxxxxxxx |
|
Xxxxxxxxx |
2,5 xxxxxxxxxx |
|
Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx: |
|
|
xxxxx 1 (xxxx Xxxxxxx) |
40 X xxxxxxxx xxxxxxxx |
|
xxxxx 2 (xxxx XXX-1) |
8 X xxxxxxxx xxxxxxxx |
|
xxxxx 3 (xxxx Xxxxxxx) |
2 X jednotek xxxxxxxx |
XXXX
1x) xxxxxxxx xxxxx xxxxx xxxxxxx, dávivému xxxxx (xxxxxxxxxx xxxxx), xxxxxx, dětské xxxxxxxx xxxxx (inaktivovaná xxxxx):
|
Xxxxxxxxxx xxxxxx |
xxxx nebo xxxxx 2 mezinárodní jednotky (2 Xx) |
|
Xxxxxxxxx xxxxxx |
xxxx xxxx xxxxx 20 xxxxxxxxxxxxx xxxxxxxx (5 Xx) |
|
Xxxxxxxxx xxxxxxxx: |
|
|
&xxxx;&xxxx; Xxxxxxxxx xxxxxx |
2,5 xxxxxxxxxx |
|
&xxxx;&xxxx; Xxxxxxxxxxxx xxxxxxxxxxxx |
5 mikrogramů |
|
Xxxxxxx xxxx 2+3 |
5 xxxxxxxxxx |
|
&xxxx;&xxxx; Xxxxxxxxx |
3 xxxxxxxxxx |
|
Xxxxx poliomyelitis xxxx 1 (inaktivovaný) |
40 xxxxxxxxxxx D xxxxxxxx |
|
Xxxxx xxxxxxxxxxxxx xxxx 2 (xxxxxxxxxxxx) |
8 xxxxxxxxxxx X xxxxxxxx |
|
Xxxxx xxxxxxxxxxxxx typu 3 (inaktivovaný) |
32 xxxxxxxxxxx X jednotek |
1m) xxxxxxxx xxxxx proti xxxxxxxxxxx (XXX xxxxxxx)
1x) očkovací xxxxx xxxxx xxxxxx xxxxxxxxxx X xxx xxxxx xxxxxxxx xx xxxxxxxxxxxx xxxxxxxx:
Xxxxxxxxx tegiminis xxxxxxxxxxx X biosyntheticum 20 mikrogramů; xxxxxxxx XX04X xxxxxxxxxx 3-X-xxxxxx-4-xxxxxxxxxxxx-xxxxx X (XXX) 50 xxxxxxxxxx v 1 xxxxx
2. Xxxxxxxxx xxxxxxx xxxxxxxxxx látek pro xxxxxxxx xxxxxxxx
2x) xxxxxxxx xxxxx proti xxxxxx xxxxxxxxxx B ve xxxxxxx xxx xxxxxxx:
|
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X |
20 xxxxxxxxxx |
2x) očkovací látka xxxxx xxxxxxxxx
2x) xxxxxxxx xxxxx proti xxxxxx xxxxxxxxxx A xx xxxxxxx pro dospělé:
Hepatitis X virus xxxxxxxxxxx
3. Xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx pro mimořádná xxxxxxxx
3x) očkovací xxxxx xxxxx virové xxxxxxxxxx X ve xxxxxxx xxx xxxxxxx:
Xxxxxxxxx X xxxxx xxxxxxxxxxx
3x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X xx xxxxxxx pro děti:
Virus xxxxxxxxx A xxxxxxxxxxx
X xxxx 2017 x xxxxxxx xx xxxxxxxxxx xxxxxxxxxx xxxxxxxx č. 537/2006 Sb., x xxxxxxxx proti xxxxxxxxx nemocem, ve xxxxx xxxxxxxxxx xxxxxxxx, xxxxx xxxxxxxx xxxxxxxxx xxxxxx antigenního složení xxxxxxxxxx xxxxx xxx xxxxxxxxxx xxxxxxxx xxxxxxxxxxxx xxxxxx xxxxxxxxxxx xxxxxxx xxxxxx očkovacích xxxxx xx Xxxxxx xxxxxx.
Xxxxxxx:
XXXx. Xxxxxxx, XXX, x. x.
Xxxxxxxxx
Xxxxxx xxxxxxx č. 390/2016 Xx. xxxxx xxxxxxxxx xxxx 17.12.2016.
Xx xxx xxxxxxxx právní xxxxxxx xxxxx xxxxx xx xxxxxxxxx.
Xxxxx xxxxxxxxxxxx xxxxxxxx norem xxxxxx xxxxxxxx xxxxxxxx v xxxxxxxx xxxx xxxxxxxxxxxxx, xxxxx xx xxxx xxxxxx derogační xxxxx xxxxx xxxxxxxxx právního xxxxxxxx.